Reclassification of papillary thyroid microcarcinoma (pMCT) according to the “Porto proposal” criteria

##plugins.themes.academic_pro.article.main##

Sarra Ben Rejeb
Dorra Aloui
Marwa Aloui
Hamdi Chouchen
Senda Turki

Abstract

Introduction: pMCT is defined as a variant of papillary carcinoma that measures≤1 cm in diameter and which is characterized by an excellent prognosis.
Recently, a proposal has been advanced to use the designation of papillary mirotumour (pMT) for pMCTs with no risk factors .

Aim: In this study, we aimed to reclassify pMCTs according to the Porto proposal(Pp) criteria.

Methods: We have retrospectively collected cases of pMCT diagnosed in our pathology department over a period of 10years(2012-2022). Clinical and
pathological parameters have been retrieved from the patient`s medical records and pathological reports. We have evaluated all cases following the
criteria of Pp. Cases that fulfilled all the criteria have been reclassified as pMT. We have briefly compared the clinical outcomes in both groups.

Results: 29 cases of pMCT was found. Mean age of patients was 46,6 years-old (17-67) with a female predominance (sex ratio=0,45). 23 cases of pMCT were incidentally
discovered. The tumor was located in the right thyroid lobe in 15cases. The mean size of the tumor was 5,2mm. Multifocality was observed in 5 cases. A total of 17 cases
could be classified as pMT according to the Pp. Only one patient developed pulmonary metastasis and local recurrence; however it was related to the papillary carcinoma
firstly diagnosed in his contralateral lobe. Clinical outcome was also good in the group of papillary microcarcinoma (pMC) with no recurrence or distant metastasis.

Conclusion: According to the Pp,>50% of pMCT could be reclassified as pMT which could reduce the psychological impact and overtreatment. Further
studies with large sample size and molecular analysis are however needed in order to definitively validate and generalize the use of Porto proposal.

Keywords:

papillary microcarcinoma - Porto proposal - papillary microtumor.

##plugins.themes.academic_pro.article.details##

References

  1. Rosai J, Albores Savedra J, Asioli S, Lloyd RV, Osamura RY, Klöppel G. Papillary thyroid carcinoma. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs, 4th edition. Lyon, France: IARC Press; 2017:81–91
  2. Londero SC, Krogdahl A, Bastholt L, et al. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance. Thyroid. 2013;23:1159–1164
  3. Rosai J, LiVolsi VA, Sobrinho-Simoes M, et al. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11:249–251.
  4. Aliyev.E, Ladra-González.M, Sánchez-Ares.M, et al. Thyroid Papillary Microtumor. Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status. The American Journal of Surgical Pathology. 2020 ;44(9) : 1161-72. doi: 10.1097/PAS.0000000000001522
  5. Colonna M, Guizard AV, Schvartz C, et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer. 2007;43:891–900.
  6. Hazard JB. Small papillary carcinoma of the thyroid. A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest. 1960;9:86–97.
  7. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56:531–538.
  8. Asioli S, Odasso C, Macrì L, et al. Merits of the PMiT (papillary microtumor) terminology in the definition of a subset of incidental papillary microcarcinomas of the thyroid. Int J Surg Pathol. 2009;17:378–383.
  9. Rosario PW. Papillary microtumor or papillary microcarcinoma of the thyroid? A prospective analysis of the Porto Proposal. Int J Surg Pathol. 2013;21:639–640.
  10. Kaliszewski K, Wojtczak B, Strutyńska-Karpińska M, et al. Incidental and non-incidental thyroid microcarcinoma. Oncol Lett. 2016;12:734–740.